Profil
Dan Shochat worked as a Principal at Wyeth Holdings LLC and Coulter Pharmaceuticals, Inc. where he held the position of Principal from 1995 to 2012.
He was also a Vice President at Deltagen, Inc., Humanigen, Inc., and Intellect Neurosciences, Inc. Additionally, he served as the Chief Technical Officer & Executive Vice President at Celscia Therapeutics, Inc. Dr. Shochat earned his doctorate degree from Louisiana State University in 1976.
He also received his undergraduate and graduate degrees from The Hebrew University of Jerusalem in 1965 and 1968, respectively.
Ehemalige bekannte Positionen von Dan Shochat
| Unternehmen | Position | Ende |
|---|---|---|
| DELTAGEN INC. | Corporate Officer/Principal | 01.01.2002 |
| INTELLECT NEUROSCIENCES, INC. | Corporate Officer/Principal | - |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
| HUMANIGEN, INC. | Corporate Officer/Principal | - |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dan Shochat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Deltagen, Inc.
Deltagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery tools and services to the biopharmaceutical industry | Commercial Services |
Humanigen, Inc.
Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Intellect Neurosciences, Inc.
Intellect Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutic agents for the treatment and prevention of neurodegenerative conditions | Health Technology |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases | Commercial Services |
Louisiana State University
Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















